February 26, 2018
CLEVELAND – University Hospitals has recruited Andrew Pieper, MD, PhD, one of the nation’s leading physician-scientists in the field of neuropsychiatric disorders. Dr. Pieper joins the Harrington Discovery Institute – part of The Harrington Project for Discovery & Development – at UH. Dr. Pieper also will be a faculty member of the Departments of Psychiatry at UH and the Louis Stokes Cleveland VA Medical Center as well as at Case Western Reserve University School of Medicine.
At the Harrington Discovery Institute, Dr. Pieper will serve as Director of the Alzheimer Drug Discovery Foundation-Harrington Scholar Program, which seeks to advance treatments for Alzheimer’s In addition, Dr. Pieper will serve as co-Director of the Gund-Harrington Scholar program which is focused on accelerating the development of vision-restoring drug therapies. In this leadership capacity, Dr. Pieper will oversee the selection and progress of the ADDF-Harrington and Gund-Harrington grant awardees annually.
“Dr. Pieper has made significant contributions to the understanding of human brain health, and his work promises new classes of medicines for Alzheimer’s disease and Parkinson’s disease,” said Jonathan S. Stamler, MD, President, Harrington Discovery Institute. “University Hospitals and Harrington Discovery Institute are very fortunate to have recruited someone of his stature to lead these partner programs, which are helping to advance breakthrough discoveries into the clinical realm.”
Dr. Pieper will work with leadership in the Harrington Discovery Institute to promote The Harrington Project mission and the translational capabilities at University Hospitals. “We look forward to Dr. Pieper’s leadership to enhance the impact of both programs nationally and internationally to address major unmet needs for diverse neuro-ophthalmological afflictions,” noted Mukesh K. Jain, Chief Scientific Officer, Harrington Discovery Institute and Chief Scientific Officer at UH.
Dr. Pieper joins UH from the University of Iowa Carver College of Medicine where he was Professor in the Department of Psychiatry and staff psychiatrist at the Iowa City Veterans Date Feb. 26, 2018 Contact: Mike Ferrari 216-844-7239 Mike.email@example.com News Release Department of Marketing and Communications 3605 Warrensville Center Road Cleveland, OH 44122 Administration Health Care System. Dr. Pieper completed his MD PhD, internal medicine, and psychiatry training at John Hopkins University School of Medicine. Following a postdoctoral fellowship at the University of Texas Southwestern (UTSW) Medical Center, he joined the faculty at UTSW from 2006-2012. In 2012 he moved to the University of Iowa where he became Director of Translational Neuroscience.
Dr. Pieper’s laboratory will continue its focus on the development of novel treatments for neuropsychiatric disorders. He is recognized for the discovery and development of the P7C3- class of neuroprotective aminopropyl carbazoles, with application in traumatic brain injury, Alzheimer’s disease, Parkinson's disease and cognitive decline with normal aging. Dr. Pieper’s lab also is implementing similar discovery approaches with other animal models of neuropsychiatric disease, such as autism, anxiety and obsessive compulsive disorder.
University Hospitals - Cleveland
2018 Harrington Investigators